Introduction
Postsynaptic metabolic pathways
Pathway name | Pathway code | Postsynaptic proteins in pathway |
---|---|---|
Energetic metabolism | ||
Glycolysis | R-MMU-70171 | 9 |
Translocation of GLUT4 to the plasma membrane | R-MMU-1445148 | 38 |
Protein metabolism | ||
Protein translation | R-MMU-72766 | 62 |
Chaperonin-mediated protein folding | R-MMU-390466 | 22 |
Different proteasome pathways | R-MMU-5610785; R-MMU-195253; R-MMU-5610780 | 33 |
Endocytosis and traffic of neurotransmitter receptors | ||
Trafficking of AMPA receptors | R-MMU-399719 | 25 |
Clathrin-mediated endocytosis | R-MMU-8856828 | 43 |
Energetic metabolism at the postsynapse
Protein metabolism at the postsynapse
Traffic of AMPA glutamate receptors and postsynaptic endocytosis
Postsynaptic metabolic disorders
Fifty-three PSD proteins involved in metabolic pathways cause inherited disease
Pathway | Gene name | Disease (OMIM) | OMIM ID |
---|---|---|---|
Energetic metabolism | |||
Glycolysis (including glucose transporters) | |||
ALDOA
| GLYCOGEN STORAGE DISEASE XII | 611881 | |
HK1
| NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE | 605285 | |
PFKM
| GLYCOGEN STORAGE DISEASE VII | 232800 | |
SLC2A1
| GLUT1 DEFICIENCY SYNDROME 2 | 612126 | |
TPI1
| TRIOSEPHOSPHATE ISOMERASE DEFICIENCY | 615512 | |
Translocation of GLUT4 to the plasma membrane | |||
MYH9 (1) | SEBASTIAN SYNDROME | 605249 | |
MYO5A
| GRISCELLI SYNDROME, TYPE 1 | 214450 | |
TUBA4A
| AMYOTROPHIC LATERAL SCLEROSIS 22 | 616208 | |
TUBA8
| CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 8 | 613180 | |
TUBB2A
| CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5 | 615763 | |
TUBB2B
| CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7 | 610031 | |
TUBB3
| FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A | 600638 | |
YWHAE
| MILLER-DIEKER LISSENCEPHALY SYNDROME | 247200 | |
YWHAG
| EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56 | 617665 | |
Protein metabolism | |||
Protein translation | |||
RPL21
| HYPOTRICHOSIS 12 | 615885 | |
RPL26
| DIAMOND-BLACKFAN ANEMIA 11 | 614900 | |
RPS10
| DIAMOND-BLACKFAN ANEMIA 9 | 613308 | |
RPS19
| DIAMOND-BLACKFAN ANEMIA 1 | 105650 | |
RPS28
| DIAMOND-BLACKFAN ANEMIA 15 | 606164 | |
RPS29
| DIAMOND-BLACKFAN ANEMIA 13 | 615909 | |
RPS14
| CHROMOSOME 5q DELETION SYNDROME | 153550 | |
RPL11
| DIAMOND-BLACKFAN ANEMIA 7 | 612562 | |
RPL35A
| DIAMOND-BLACKFAN ANEMIA 5 | 612528 | |
RPS23
| BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY | 617412 | |
RPL5
| DIAMOND-BLACKFAN ANEMIA 6 | 612561 | |
Chaperonin-mediated protein folding | |||
CCT5
| NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA | 256840 | |
CSNK2A1
| OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME | 617062 | |
GNAI2
| VENTRICULAR TACHYCARDIA, FAMILIAL | 192605 | |
GNAI3
| AURICULOCONDYLAR SYNDROME 1 | 602483 | |
GNAO1
| NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS | 617493 | |
GNAO1
| EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17 | 615473 | |
GNB3
| NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H | 617024 | |
GNB4
| CHARCOT-MARIE-TOOTH DISEASE | 615185 | |
GNB5
| LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER | 617182 | |
RGS9
| PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION | 608415 | |
Different proteasome pathways | |||
APC
| FAMILIAL ADENOMATOUS POLYPOSIS 1 | 175100 | |
CTNNB1
| MENTAL RETARDATION, AUTOSOMAL DOMINANT 19 | 615075 | |
PPP2R1A
| MENTAL RETARDATION, AUTOSOMAL DOMINANT 36 | 616362 | |
Endocytosis and traffic of neurotransmitter receptors | |||
Trafficking of AMPA receptors | |||
AP2S1 (2) | HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III | 600740 | |
CACNG2
| MENTAL RETARDATION, AUTOSOMAL DOMINANT 10 | 614256 | |
CAMK2A
| MENTAL RETARDATION, AUTOSOMAL DOMINANT 53 | 617798 | |
CAMK2B
| MENTAL RETARDATION, AUTOSOMAL DOMINANT 54 | 617799 | |
EPB4.1 L1
| MENTAL RETARDATION, AUTOSOMAL DOMINANT 11 | 614257 | |
GRIA3
| MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE | 300699 | |
GRIA4
| NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES | 617864 | |
GRIP1
| FRASER SYNDROME 3 | 617667 | |
MYO6
| DEAFNESS, AUTOSOMAL DOMINANT 22 | 606346 | |
PRKCG
| RETINITIS PIGMENTOSA 11 | 600138 | |
PRKCG
| SPINOCEREBELLAR ATAXIA 14 | 605361 | |
Clathrin-mediated endocytosis | |||
ACTB (3) | BARAITSER-WINTER SYNDROME 1 | 243310 | |
ACTG1 (3) | BARAITSER-WINTER SYNDROME 2 | 614583 | |
DNM2
| CHARCOT-MARIE-TOOTH DISEASE | 606482 | |
NECAP1
| EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21 | 615833 | |
PIP5K1C
| LETHAL CONGENITAL CONTRACTURE SYNDROME 3 | 611369 | |
WNT5A
| ROBINOW SYNDROME, AUTOSOMAL DOMINANT 1 | 189700 |
Most inherited diseases caused by metabolism proteins in the PSD show neurological symptoms
Pathway | Intellectual disability | Seizures | Microcephaly | Generalised hypotonia | Migraine | Specific learning disability | Hypoplasia of the corpus callosum | Hyporeflexia | Spasticity |
---|---|---|---|---|---|---|---|---|---|
Energetic metabolism | |||||||||
Glycolysis (including glucose transporters) | 2 | 2 | 1 | 1 | 0 | 1 | 0 | 2 | 3 |
Translocation of GLUT4 to the plasma membrane | 2 | 7 | 3 | 2 | 0 | 2 | 4 | 1 | 2 |
Protein metabolism | |||||||||
Protein translation | 1 | 0 | 2 | 1 | 9 | 0 | 0 | 0 | 0 |
Chaperonin-mediated protein folding | 2 | 1 | 1 | 2 | 0 | 0 | 1 | 1 | 0 |
Different proteasome pathways | 2 | 3 | 3 | 3 | 0 | 0 | 2 | 0 | 0 |
Endocytosis and traffic of neurotransmitter receptors | |||||||||
Trafficking of AMPA receptors | 6 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 |
Clathrin-mediated endocytosis | 3 | 3 | 2 | 3 | 0 | 3 | 0 | 1 | 0 |
Total | 18 | 17 | 13 | 12 | 9 | 6 | 7 | 6 | 5 |